BRIEF-Mesoblast Says Co & Lonza Enter Agreement For Commercial Manufacture Of Co's Allogeneic Cell Therapy - Reuters

Oct 17 (Reuters) - Mesoblast:

* CO & LONZA ENTER AGREEMENT FOR COMMERCIAL MANUFACTURE OF MESOBLAST’S POTENTIAL FIRST UNITED STATES ALLOGENEIC CELL THERAPY

* EXPECTS TO COMPLETE FILING OF ROLLING BIOLOGICS LICENSE APPLICATION SUBMISSION TO US FDA BY THE END OF THIS YEAR Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.

Let's block ads! (Why?)

Read Again https://www.reuters.com/article/brief-mesoblast-says-co-lonza-enter-agre/brief-mesoblast-says-co-lonza-enter-agreement-for-commercial-manufacture-of-cos-allogeneic-cell-therapy-idUSFWN2710TB

Bagikan Berita Ini